Lisanne E Heeger1, Clare E Counsilman1, Vincent Bekker1, Klasien A Bergman2, Jaap Jan Zwaginga3,4, Arjan B Te Pas1, Enrico Lopriore1. 1. Division of Neonatology, Department of Pediatrics, Leiden University Medical Center, Leiden, The Netherlands. 2. Division of Neonatology, University Medical Center Groningen, Beatrix Children's Hospital, University Groningen, Groningen, The Netherlands. 3. Sanquin Research, Center for Clinical Transfusion Research, Leiden, The Netherlands. 4. Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands.
Abstract
OBJECTIVE: To evaluate red blood cell (RBC) transfusion practices in preterm neonates before and after protocol change. METHODS: All preterm neonates (<32 weeks of gestation) admitted between 2008 and 2017 at our neonatal intensive care unit were included in this retrospective study. Since 2014, a more restrictive transfusion guideline was implemented in our unit. We compared transfusion practices before and after this guideline change. Primary outcome was the number of transfusions per neonate and the percentage of neonates receiving a blood transfusion. Secondary outcomes were neonatal morbidities and mortality during admission. RESULTS: The percentage of preterm neonates requiring a blood transfusion was 37·5% (405/1079) before and 32·7% (165/505) after the protocol change (P = 0·040). The mean number of transfusions given to each transfused neonate decreased from 2·93 (standard deviation (SD) ± 2·26) to 2·20 (SD ±1·29) (P = 0·007). We observed no association between changes in transfusion practices and neonatal outcome. CONCLUSION: The use of a more restrictive transfusion guideline leads to a reduction in red blood cell transfusions in preterm neonates, without evidence of an increase in mortality or short-term morbidity.
OBJECTIVE: To evaluate red blood cell (RBC) transfusion practices in preterm neonates before and after protocol change. METHODS: All preterm neonates (<32 weeks of gestation) admitted between 2008 and 2017 at our neonatal intensive care unit were included in this retrospective study. Since 2014, a more restrictive transfusion guideline was implemented in our unit. We compared transfusion practices before and after this guideline change. Primary outcome was the number of transfusions per neonate and the percentage of neonates receiving a blood transfusion. Secondary outcomes were neonatal morbidities and mortality during admission. RESULTS: The percentage of preterm neonates requiring a blood transfusion was 37·5% (405/1079) before and 32·7% (165/505) after the protocol change (P = 0·040). The mean number of transfusions given to each transfused neonate decreased from 2·93 (standard deviation (SD) ± 2·26) to 2·20 (SD ±1·29) (P = 0·007). We observed no association between changes in transfusion practices and neonatal outcome. CONCLUSION: The use of a more restrictive transfusion guideline leads to a reduction in red blood cell transfusions in preterm neonates, without evidence of an increase in mortality or short-term morbidity.
Authors: Minesh Khashu; Christof Dame; Pascal M Lavoie; Isabelle G De Plaen; Parvesh M Garg; Venkatesh Sampath; Atul Malhotra; Michael D Caplan; Praveen Kumar; Pankaj B Agrawal; Giuseppe Buonocore; Robert D Christensen; Akhil Maheshwari Journal: Newborn (Clarksville) Date: 2022-03-31
Authors: Alexander Fuchs; Nicola Disma; Katalin Virág; Francis Ulmer; Walid Habre; Jurgen C de Graaff; Thomas Riva Journal: Eur J Anaesthesiol Date: 2022-03-01 Impact factor: 4.330